Prospective Randomized Phase-II Trial With Temsirolimus Versus Sunitinib in Previously Untreated Patients With Advanced or Metastatic Non-Clear Cell Renal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2014
At a glance
- Drugs Sunitinib (Primary) ; Temsirolimus (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 03 Jul 2013 New source identified and integrated (German Clinical Trials Register, DRKS00004138).
- 21 Jul 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2009-010143-13).
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.